The Levels of Inhibitory Cytokines in the Serum of Patients with Hepatitis B and C

Ainor Rohmah, Sigit Setyawan, Tri Nugraha Susilawati


Hepatitis B and C Viruses (HBV dan HCV) can cause acute or chronic hepatitis that may develop into fibrosis, cirrhosis, and hepatocarcinoma. Previous studies have reported that hepatocyte damage is mainly due to overactive immune responses rather than viral infection. Cytokines are essential mediators in the immune response. This study aimed to determine the correlation between the levels of serum inhibitory cytokines, i.e., IL-4, IL-10, and TGF-β, and the development of liver disease in patients with hepatitis B and C. The levels of serum IL-4, IL-10, and TGF-β from 58 patients with hepatitis B or hepatitis C were determined by ELISA. The progression of liver disease is inferred from the levels of serum transaminases and the degree of liver fibrosis. Data were analyzed using the Spearman correlation test with a p-value of < 0.05 is considered statistically significant. This study showed no correlation between the levels of serum IL-4, IL-10, and TGF-β and the development of liver disease in patients with hepatitis B and C (p > 0.05). Therefore, cytokine testing using ELISA was unable to replace liver biopsy to assess liver disease progression in patients with hepatitis B and C.


IL-4, IL-10, TGF-β, disease progression, hepatitis B, hepatitis C

Full Text:



#tab=tab_1 (accessed 6 Jan, 2021)

detail/hepatitis-b (accessed 11 Des, 2020)

hepatitis-c (accessed 11 Des, 2020)


-hepatitis-in-indonesia-a-po (accessed 5 Jan, 2021)

Muldoon D. Epidemiology of hepatitis B and C

in Republic of Indonesia. Euroasian Journal of

Hepato-Gastroenterology, 2017; 7: 55-59.

Mauss B, Rockstroh S, Wedemeyer. Hepatology a

th clinical textbook. 10 Ed., Germany, GILEAD, 2020;


Khan S, Bhargava A, Pathak N, Maudar KK, et al.Circulating biomarkers and their possible role in

pathogenesis of chronic hepatitis B and C viral

infections. Indian Journal of Clinical Biochemistry,

; 26(2): 161-168.

Zdravkovic N, Rosic M, Lutovac M, Zdravkovic V.

Physiology and Pathology of Cytokine: Commercial

Production and Medical Use. Intech. 2018;


Tiniakos DG, Brain JG, Bury YA. Role of histopathology

in autoimmune hepatitis. Dig Dis, 2015; 33(2): 53-64.

Czaja AJ. Diagnosis and Management of Autoimmune

Hepatitis: Current Status and Future Directions. Gut

Liver, 2016; 10(2): 177-203.

Magda R, Anna W, Alicja S, Tomasz R, Piotr S, et al.

Genetic variation in IL-10 influences the progression

of hepatitis B infection. International Journal of

Infectious Diseases, 2020; 96: 260-265.

Cai GF, Wang ZT, Yao J, Liu K, Wang Z, et al. The

correlation between serum cytokine levels and

liver cirrhosis in chronic hepatitis B patients: A

meta-analysis. Archives of Hepatitis Research, 2018;

(1): 6-12.


Nov, 2020)

https ://apps s /bit s tream/10665/

/1/9789241548755_eng.pdf. (accessed 6 Aug,

Stein SM. BOH'S pharmacy practice manual: A guide to

rd the clinical experience. 3 Ed., Philadelphia, Lippincott

Williams & Wilkins, 2010; 117-196.

Liao R, Fu YP, Wang T, Deng ZG, Li DW, et al. Metavir

and FIB-4 scores are associated with patient prognosis

after curative hepatectomy in hepatitis B virus-related

hepatocellular carcinoma: A retrospective cohort

study at two centers in China. Oncotarget, 2017; 8(1):


Pokharel N, Bhandari D, Jha B. Pattern of hepatitis B

and C infections among patients attending a tertiary

care hospital in Kathmandu, Nepal. Journal of Institute

of Medicine, 2017; 40.

Neoh H, Saimin S, Jamal R. Seroprevalence of hepatitis

B and C in healthy Malaysian adults: A preliminary

report. Journal of Biomedicine and Translational

Research, 2019; 5: 23.

(accessed 18 June, 2020).

(accessed 18 June, 2020)

Soe KP, Pan-ngum W, Nontprasert A, Kittitrakul C,

Oam N, et al. Awareness, knowledge, and practice for

hepatitis B infection in Southeast Asia: a cross-sectional

study. J Infect Dev Ctries, 2019; 13: 656-664.

Viky NRM, Puspa W, Bagus S. AST, ALT and albumin

level in chronic hepatitis B patients with and without

complications of cirrhosis and hepatocellular

carcinoma. Indonesian Journal of Clinical Pathology

and Medical Laboratory, 2020; 26(3): 344-349.


elevated-liver-enzymes-hepatitis/. (accessed 30 May,


h t t p s :// w w w . i n f e c t i o u s d i s e a s e a d v i s o r .



-at-a-safety-net -hospital/ (accessed 13 Feb, 2021).

Liu C, Wang L, Xie H, Zhang L, Wang B, et al. The

relationship between serum hepatitis B virus DNA

level and liver histology in patients with chronic HBV

infection. PLoS One, 2018; 13(11): e0206060.

European Association for the Study of the Liver.

Clinical practice guidelines on the management of

hepatitis B virus infection. Journal of Hepatology,

; 67(2): 370-398.

Danlu W, Trinh LD, Bruce PB, David RW. Long-term

measurements of human inflammatory cytokines

reveal complex baseline variations between

individuals. The American Journal of Pathology, 2017;

(12): 2620-26.

Lugos MD, Polit UY, Damen JG. A study on the impact

of repeated freeze-thaw cycles on the serum cytokine

Enzyme-Linked Immunosorbent Assay (ELISA). Int. J.

Med. Lab. Res, 2018; 3(2): 29-36.

Agrawal L, Engel KB, Greytak SR, Moore HM.

Understanding pre-analytical variables and their effects

on clinical biomarkers of oncology and immunotherapy.

Semin Cancer Biol. 2018; 52(Pt 2): 26-38.

Samantha S, Janina K, Seth G, Lubna P. Thermal

stability of cytokines: A review. Cytokine. 2020; 125:

González DR, González DÁ, Sayago A, Fernández RÁ.

Recommendations and best practices for

standardizing the pre-analytical processing of blood

and urine samples in metabolomics. Metabolites,

; 10(6): 229.

Albanian WK, Fathy SA, Ibrahim RA, Hegazy MGA.

Assessment of interleukin 17 and transforming growth

factor-beta 1 in hepatitis C patients with disease

progression. Trop Biomed, 2020; 37(4): 1093-1104.

Hosseini KSH, Nejatollahi F, Davarpanah MA. Serum

levels of interleukin-4, interleukin-10 and interferon-γ

in patients with chronic hepatitis B infection. Hepat

Mon, 2018; 18(4): e60377.

Gu Y, Lian Y, Gu L, Chen L, Li X, et al. Correlations

between cytokines produced by T-cells and

clinical-virological characteristics in untreated chronic

hepatitis B patients. BMC Infect Dis, 2019; 19(1): 216.

Tian F, Liu Y, Gao J, Yang N, Shang X, et al. Study on the

association between TGF-β1 and liver fibrosis in

patients with hepatic cystic echinococcosis.

Experimental and Therapeutic Medicine. 2020; 19:


Ming DS, Lin ZZ, Qiu XD. Analysis of IL-6, IL-10, IL-17

levels in the blood of patients with chronic hepatitis B.

Int J Clin Exp Med, 2016; 9(6): 9437-9442.

Batsaikhan B, Lu MY, Yeh ML, Huang CI, Huang CF,

et al. Elevated interleukin-4 levels predicted advanced

fibrosis in chronic hepatitis C. JCMA, 2019; 277-281.

Li H, Huang MH, Jiang JD, Peng ZG. Hepatitis C: From

inflammatory pathogenesis to anti-inflammatory/

hepatoprotective therapy. World Journal of

Gastroenterology, 2018; 24(47): 5297-5311

Strunk KK, Mwavita M. Design and analysis in

st educational research: ANOVA designs in SPSS®, 1

Ed., London, Routledge, 2020; 24-26



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.